Humanigen Inc (fka HGENQ)

[cowtown jay]

I wonder if our interest in TeraImmune, through Baudax, is reflective of Moderna's interest in collaboration with Immatics NV. I've got to look at what TeraImmune and Immatics are doing, in comparison to each other. Immatics does have a simple 5 minute video illustration of their effort to develop the right T cell receptors to target cancer immunotherapies.

https://immatics.com/ See "Our mission"

FYI: "Regarding oncology, Moderna announced on Monday a multi-year collaboration with biotechnology company Immatics NV, on a variety of products, including antibodies produced through mRNA and cancer vaccines."

https://finance.yahoo.com/news/moderna-covid-shots-grow-revenue-105341755.html

This just sounds like the Treg work TeraImmune is doing, as well what our latest CAR-T patent is advancing.

"Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab
Patent number: 11673962
Abstract: Methods of inhibiting or reducing the incidence or the severity of immunotherapy-related toxicity in a subject, the method comprising a step of administering a recombinant hGMCSF antagonist to the subject, wherein said administering inhibits or reduces the incidence or the severity of immunotherapy-related toxicity in said subject, are provided. An hGMCSF antagonist for use in methods of inhibiting or reducing the incidence or the severity of immunotherapy-related toxicity in a subject also are provided.
Type: Grant
Filed: October 2, 2018
Date of Patent: June 13, 2023
Assignee: HUMANIGEN, INC.
Inventors: Cameron Durrant, Dale Chappell"

https://patents.justia.com/assignee/humanigen-inc